Vaxart, Inc. (VXRT)
0.61
-0.02
(-3.13%)
USD |
OTCM |
Apr 02, 16:00
Vaxart EPS Diluted (Quarterly) : 0.2289 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 0.0546 |
| Nuwellis, Inc. | -1.500 |
| Capricor Therapeutics, Inc. | -0.6176 |
| Allogene Therapeutics, Inc. | -0.1717 |
| Silvergate Capital Corp. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 55.04M |
| Revenue (Quarterly) | 104.24M |
| Total Expenses (Quarterly) | 49.19M |
| Enterprise Value | 96.14M |
| Gross Profit Margin (Quarterly) | 98.03% |
| Profit Margin (Quarterly) | 52.81% |
| Earnings Yield | 10.04% |
| Operating Earnings Yield | 13.22% |
| Normalized Earnings Yield | 10.04 |